Universitair Ziekenhuis Leuven

Publications in OpenAlex of which a co-author is affiliated to this organization

All publications | By field | By subfield

All publications [Next]
Title DOI
https://doi.org/10.1016/s0140-6736(10)61121-x Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
https://doi.org/10.1038/362059a0 Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
https://doi.org/10.1080/15548627.2015.1100356 Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
https://doi.org/10.1038/nm.3967 The consensus molecular subtypes of colorectal cancer
https://doi.org/10.1056/nejmoa033025 Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
https://doi.org/10.1109/42.563664 Multimodality image registration by maximization of mutual information
https://doi.org/10.1016/s0140-6736(02)08512-4 Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
https://doi.org/10.1056/nejmoa050516 Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
https://doi.org/10.1056/nejmoa0805019 Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
https://doi.org/10.1053/j.gastro.2011.07.050 Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma, Adenocarcinoma, and Barrett's Epithelium
https://doi.org/10.1056/nejmoa022457 Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
https://doi.org/10.2337/dci18-0033 Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
https://doi.org/10.1056/nejmoa062867 Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia
https://doi.org/10.1056/nejm199710093371502 A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease
https://doi.org/10.1200/jco.2007.14.7116 Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
https://doi.org/10.1136/gut.2005.082909 The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications
https://doi.org/10.1056/nejmoa0904492 Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
https://doi.org/10.1016/s0140-6736(15)01124-1 Alzheimer's disease
https://doi.org/10.1002/nau.20798 An international urogynecological association (IUGA)/international continence society (ICS) joint report on the terminology for female pelvic floor dysfunction
https://doi.org/10.1200/jco.2003.10.038 Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer
https://doi.org/10.1056/nejmoa2017699 Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer
https://doi.org/10.1016/j.clnu.2018.08.037 ESPEN guideline on clinical nutrition in the intensive care unit
https://doi.org/10.1056/nejmoa1003825 Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
https://doi.org/10.1037/abn0000362 WHO World Mental Health Surveys International College Student Project: Prevalence and distribution of mental disorders.
https://doi.org/10.1007/s00192-009-0976-9 An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction
https://doi.org/10.1136/bmj.i6583 Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data
https://doi.org/10.1016/s0140-6736(18)32552-2 Epithelial ovarian cancer
https://doi.org/10.1056/nejmoa061094 Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
https://doi.org/10.1056/nejmoa040331 A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer
https://doi.org/10.1053/j.gastro.2005.11.030 Human Anti–Tumor Necrosis Factor Monoclonal Antibody (Adalimumab) in Crohn’s Disease: the CLASSIC-I Trial
https://doi.org/10.1056/nejmoa2032125 Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer
https://doi.org/10.1136/bmj.38985.646481.55 Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)
https://doi.org/10.1200/jco.2017.73.7585 MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2− Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy
https://doi.org/10.1056/nejmoa1409547 Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508delCFTR
https://doi.org/10.1007/s10029-009-0529-7 European Hernia Society guidelines on the treatment of inguinal hernia in adult patients
https://doi.org/10.1016/s1470-2045(20)30109-1 Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
https://doi.org/10.1017/s0033291716001665 Mental disorders among college students in the World Health Organization World Mental Health Surveys
https://doi.org/10.1016/s0140-6736(05)67063-8 Endometrial cancer
https://doi.org/10.1007/s00125-018-4729-5 Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
https://doi.org/10.1056/nejmoa062437 Bivalirudin for Patients with Acute Coronary Syndromes
https://doi.org/10.1016/s0195-668x(02)00618-8 Management of acute myocardial infarction in patients presenting with ST-segment elevation
https://doi.org/10.1056/nejmoa1908075 Encorafenib, Binimetinib, and Cetuximab in BRAF V600E–Mutated Colorectal Cancer
https://doi.org/10.1016/s0140-6736(01)06103-7 Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial
https://doi.org/10.1056/nejmoa1414325 Randomized Trial of TAS-102 for Refractory Metastatic Colorectal Cancer
https://doi.org/10.1182/blood.2022015851 The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
https://doi.org/10.1007/s10029-009-0518-x Classification of primary and incisional abdominal wall hernias
https://doi.org/10.1016/j.healun.2014.06.014 A consensus document for the selection of lung transplant candidates: 2014—An update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation
https://doi.org/10.1183/13993003.00629-2017 European Respiratory Society guidelines for the management of adult bronchiectasis
https://doi.org/10.1016/s0140-6736(05)67861-0 Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial
https://doi.org/10.1016/s0140-6736(01)06535-7 Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study
https://doi.org/10.1093/jnci/92.14.1143 Long-Term Results of a Randomized Trial Comparing Breast-Conserving Therapy With Mastectomy: European Organization for Research and Treatment of Cancer 10801 Trial
https://doi.org/10.1053/j.gastro.2011.10.032 Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis
https://doi.org/10.1016/s0140-6736(08)60304-9 Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial
https://doi.org/10.1111/1469-0691.12039 ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients
https://doi.org/10.1016/j.placenta.2005.12.006 The Uterine Spiral Arteries In Human Pregnancy: Facts and Controversies
https://doi.org/10.2337/dci19-0066 2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
https://doi.org/10.1056/nejmoa1706640 Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
https://doi.org/10.1016/s1470-2045(12)70477-1 Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial
https://doi.org/10.1056/nejmoa1611977 Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma
https://doi.org/10.1097/00054725-200002000-00002 A Simple Classification of Crohnʼs Disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998
https://doi.org/10.1016/s0140-6736(05)67101-2 Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911)
https://doi.org/10.1056/nejmoa031633 Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis
https://doi.org/10.1056/nejmoa1203572 Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease
https://doi.org/10.1001/jamaoncol.2020.3370 Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer
https://doi.org/10.1136/gut.2010.223263 Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives
https://doi.org/10.1056/nejmoa035075 Treatment of Rheumatoid Arthritis by Selective Inhibition of T-Cell Activation with Fusion Protein CTLA4Ig
https://doi.org/10.1093/annonc/mdy308 Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
https://doi.org/10.1038/nature06882 Human metabolic phenotype diversity and its association with diet and blood pressure
https://doi.org/10.1016/s0140-6736(11)61742-x Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study
https://doi.org/10.1016/j.eururo.2006.11.013 A Prospective Randomized EORTC Intergroup Phase 3 Study Comparing the Complications of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma
https://doi.org/10.1016/j.eururo.2010.12.013 A Prospective, Randomised EORTC Intergroup Phase 3 Study Comparing the Oncologic Outcome of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma
https://doi.org/10.1136/gut.2006.106781 Adalimumab for maintenance treatment of Crohn’s disease: results of the CLASSIC II trial
https://doi.org/10.1016/j.jhep.2014.06.012 Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure
https://doi.org/10.1016/s0140-6736(98)03085-2 Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer
https://doi.org/10.1200/jco.19.02107 Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability–High/Mismatch Repair–Deficient Metastatic Colorectal Cancer: KEYNOTE-164
https://doi.org/10.1164/rccm.202005-2032st Diagnosis of Hypersensitivity Pneumonitis in Adults: An Official ATS/JRS/ALAT Clinical Practice Guideline
https://doi.org/10.1001/jamaoncol.2019.4782 The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor–Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy—MONARCH 2
https://doi.org/10.7326/0003-4819-146-12-200706190-00159 Adalimumab Induction Therapy for Crohn Disease Previously Treated with Infliximab
https://doi.org/10.1016/s0140-6736(15)01159-9 Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial
https://doi.org/10.1212/01.wnl.0000156155.19270.f8 Multiple Sclerosis Severity Score
https://doi.org/10.1053/j.gastro.2003.11.014 Comparison of scheduled and episodic treatment strategies of infliximab in Crohn’s disease
https://doi.org/10.1136/gut.2005.069476 Laboratory markers in IBD: useful, magic, or unnecessary toys?
https://doi.org/10.1200/jco.20.02514 Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2−, Node-Positive, High-Risk, Early Breast Cancer (monarchE)
https://doi.org/10.1016/s1470-2045(15)70127-0 Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study
https://doi.org/10.1016/s0140-6736(19)31240-1 Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study
https://doi.org/10.1056/nejmoa043335 Natalizumab Induction and Maintenance Therapy for Crohn's Disease
https://doi.org/10.1056/nejmoa040446 Caspofungin versus Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Persistent Fever and Neutropenia
https://doi.org/10.1371/journal.pmed.1000123 Cross-National Analysis of the Associations among Mental Disorders and Suicidal Behavior: Findings from the WHO World Mental Health Surveys
https://doi.org/10.1053/j.gastro.2011.06.054 Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis
https://doi.org/10.1016/s0140-6736(07)60200-1 Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial
https://doi.org/10.1213/00000539-199412000-00024 Anticoagulants and Spinal-Epidural Anesthesia
https://doi.org/10.1016/s0140-6736(12)61253-7 Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)
https://doi.org/10.1016/s0143-4004(80)80012-9 Trophoblastic invasion of human decidua from 8 to 18 weeks of pregnancy
https://doi.org/10.1016/j.jaci.2004.09.029 Rhinosinusitis: Establishing definitions for clinical research and patient care
https://doi.org/10.1172/jci108740 The Interdigestive Motor Complex of Normal Subjects and Patients with Bacterial Overgrowth of the Small Intestine
https://doi.org/10.1053/j.gastro.2009.09.056 Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease
https://doi.org/10.1056/nejmoa1911149 Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer
https://doi.org/10.1136/gutjnl-2016-313235 A microbial signature for Crohn's disease
https://doi.org/10.1056/nejmoa0901409 High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia
https://doi.org/10.1038/cr.2010.150 Neutrophil extracellular trap cell death requires both autophagy and superoxide generation